A18.53 Tuberculous chorioretinitis

Name of the Condition

• Tuberculous chorioretinitis
• ICD Code: A18.53

Summary

Tuberculous chorioretinitis is a rare form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects the choroid and retina of the eye. This condition occurs when TB bacteria spread from a primary site, typically the lungs, to the eye via the bloodstream or lymphatic system. It can cause inflammation and damage to these structures, potentially leading to vision impairment if not promptly diagnosed and treated.

Causes

Tuberculous chorioretinitis is caused by the dissemination of Mycobacterium tuberculosis from an existing infection, usually pulmonary tuberculosis. The bacteria can travel to the choroid and retina during active disease or reactivation of latent TB. Direct inoculation is rare but possible in certain cases.

Risk Factors

• Immunocompromised states, such as HIV/AIDS or chronic immunosuppressive therapy.
• History of untreated or inadequately treated tuberculosis.
• Close contact with individuals who have active TB.
• Living in or traveling to regions with high TB prevalence.
• Underlying conditions like diabetes or malnutrition.

Symptoms

• Decreased vision or blurred vision.
• Floaters or seeing spots.
• Eye pain and sensitivity to light (photophobia).
• Redness and swelling in the eye.
• Discharge or tearing.

Diagnosis

Diagnosis involves a comprehensive eye examination, including slit-lamp evaluation and fundoscopy to assess the retina and choroid. Imaging studies like optical coherence tomography (OCT) or fluorescein angiography may be used to visualize lesions. Laboratory tests, such as sputum or tissue cultures, or molecular tests (e.g., PCR) for Mycobacterium tuberculosis may confirm the diagnosis. A thorough medical history and evaluation for systemic TB are also essential.

Treatment Options

Treatment typically involves a standard course of anti-tuberculosis medications, such as isoniazid, rifampin, ethambutol, and pyrazinamide, often for 6–9 months. Corticosteroids may be prescribed to reduce inflammation and prevent vision loss. Close monitoring by an ophthalmologist and infectious disease specialist is recommended to manage the condition and address any complications.

Prognosis and Follow-Up

With prompt and appropriate treatment, the prognosis for tuberculous chorioretinitis is generally favorable, though vision impairment may occur if damage is severe or treatment is delayed. Regular follow-up appointments are necessary to monitor for recurrence, assess treatment response, and address any residual symptoms or complications.

Complications

• Permanent vision loss or blindness.
• Retinal detachment.
• Cataracts.
• Glaucoma.
• Spread of infection to other parts of the eye or body.

Lifestyle & Prevention

• Maintain good overall health to support immune function.
• Avoid close contact with individuals who have active TB.
• Follow infection control measures in high-risk settings.
• Complete prescribed TB treatment if diagnosed with latent or active TB.
• Seek prompt medical attention for eye symptoms, especially in high-prevalence regions.

When to Seek Professional Help

Seek immediate medical care if you experience sudden vision changes, severe eye pain, or persistent redness, swelling, or discharge. Early evaluation is critical to prevent permanent damage and ensure appropriate treatment.

Tips for Medical Coders

When coding for tuberculous chorioretinitis (A18.53), ensure documentation specifies the involvement of both the choroid and retina. Verify that the diagnosis is supported by clinical findings, such as fundoscopic evidence of lesions or laboratory confirmation of Mycobacterium tuberculosis. Avoid using this code for isolated choroidal or retinal TB; use the appropriate subcategory if only one structure is affected. Document any associated systemic TB or risk factors to support the diagnosis.